What Are Pleural Plaques and Are They Serious?

Understand pleural plaques: learn what these common lung findings are and their true implications for your health.

Pleural plaques are flat patches of scar-like tissue that form on the lining of the chest wall, almost always as a result of breathing in asbestos fibers years or decades earlier. They are the most common sign of past asbestos exposure, and on their own they are generally not dangerous. Most people with pleural plaques have no symptoms and no meaningful loss of lung function. But their presence is not entirely benign in the broader picture, because the same exposure history that produced the plaques also raises the risk of more serious asbestos-related diseases, including mesothelioma.

What Pleural Plaques Actually Are

The pleura is a thin, two-layered membrane that lines the chest cavity and wraps around the lungs. Pleural plaques develop on the parietal pleura, the outer layer that sits against the chest wall and the upper surface of the diaphragm. Under a microscope, they consist of densely packed, interwoven bundles of collagen with very few cells or blood vessels. To the naked eye during surgery or autopsy, they look like pale white or yellowish patches with a rough, waxy surface sometimes described as resembling candle wax drippings.

These patches are sharply demarcated, meaning they have clear borders that separate them from the surrounding normal pleura. They tend to cluster along the lower chest wall and on the dome of the diaphragm. Over time some of them calcify, becoming hard and dense enough to show up clearly on a standard chest X-ray. Whether or not they calcify, they can continue to grow slowly for years, even long after the person has stopped being exposed to asbestos.

How Asbestos Fibers Reach the Pleura

When asbestos fibers are inhaled, they first lodge in the lung tissue itself. Getting from there to the pleural lining requires crossing tissue barriers, and researchers have identified two main routes. One path involves fibers migrating through the lung tissue and reaching the visceral pleura (the inner layer that coats the lungs), then entering the thin layer of fluid that sits between the two pleural surfaces. The other route follows the natural drainage of pleural fluid. Your body constantly produces and reabsorbs a small amount of fluid in the pleural space, and that fluid drains through tiny openings called stomata on the parietal pleura, particularly along the diaphragm and near the mediastinum. Asbestos fibers carried by this fluid collect at those drainage points because their elongated shape makes them too awkward to pass through the narrow lymphatic channels. Plaques form precisely at the sites where these stomata are concentrated.

This explains the characteristic distribution pattern of pleural plaques. They appear where fluid drainage is most active, which is why the diaphragm, lower chest wall, and mediastinal areas are the most common sites. It also explains why plaques tend to spare the lung apices (the very top of the lungs) and the costophrenic angles (the sharp corners where the diaphragm meets the chest wall), areas where stomatal drainage is less active.

How Long After Exposure Do They Appear

Pleural plaques take a surprisingly long time to develop. Mathematical modeling of exposed populations has estimated a latency period of roughly 13 years from the onset of asbestos exposure before plaques begin to appear.

After that initial lag, the likelihood of developing plaques continues to rise with time. A study of over 5,500 asbestos-exposed workers found that time since first exposure was the strongest predictor of plaques, even more reliable than the total amount of asbestos inhaled, though cumulative dose also mattered independently.

This long delay is one reason why pleural plaques are still diagnosed regularly today, decades after most Western countries restricted asbestos use. Someone who worked in construction or shipbuilding in the 1970s or 1980s might first see plaques on a scan in the 2010s or 2020s. The plaques themselves can also progress after exposure ceases. They grow slowly, and some eventually calcify, making them more visible on imaging over the years.

How They Are Diagnosed

Most pleural plaques are discovered incidentally, showing up on a chest X-ray or CT scan ordered for an unrelated reason. Standard chest X-rays can detect them, particularly when the plaques are calcified, but X-rays have real limitations. Fat deposits just beneath the pleura, muscles, and even companion shadows along ribs can mimic the appearance of plaques, leading to false positives. One study found that when chest radiographs were read by outside radiologists, the positive predictive value for pleural disease was only about 56%, meaning nearly half the time a “positive” reading was wrong. High-resolution CT scanning brought that figure up to 100%.

CT scans are substantially better at both finding real plaques and ruling out false alarms, with reported sensitivity of 93 to 100% and specificity of 83 to 100%.

If you have a history of asbestos exposure and a chest X-ray suggests plaques, your doctor may recommend a CT scan to confirm the diagnosis and to check for other asbestos-related changes in the lungs.

Do Pleural Plaques Hurt Your Breathing

This is probably the most common worry people have when they learn they have pleural plaques, and the evidence is mostly reassuring. A systematic review that focused on the highest-quality CT-based studies found no consistent pattern of reduced lung function in people with plaques compared to those without. Across six well-designed studies, the differences in standard lung function measures between the plaque group and normal group were small and inconsistent, ranging from slightly lower to slightly higher in the plaque group.

Some research has hinted that when the total volume of plaque tissue is larger, lung function measures tend to be slightly lower, but these trends have not reached statistical significance in controlled studies.

The upshot is that isolated pleural plaques, without other asbestos-related lung disease, do not appear to cause clinically meaningful breathing problems for most people. If you have plaques and find yourself short of breath, your doctor should investigate other possible causes rather than attributing it to the plaques alone.

The Distinction from Diffuse Pleural Thickening

Pleural plaques are often confused with a different condition called diffuse pleural thickening, and the distinction matters because the two conditions behave quite differently. Plaques are discrete, well-bordered patches that arise from the parietal (outer) pleura. Diffuse pleural thickening, by contrast, arises from the visceral (inner) pleura, has blurred edges, and extends fibrous strands into the lung tissue itself. Diffuse thickening is more likely to impair breathing and carry a worse prognosis.

The two conditions frequently coexist in the same patient, since both result from asbestos exposure. But someone who has only plaques, without diffuse thickening or asbestosis (scarring of the lung tissue itself), generally has a better outlook. Medical and legal evaluations of asbestos-exposed workers treat these as separate diagnoses with different implications for disability and compensation.

What Else Can Look Like Pleural Plaques

While asbestos accounts for the vast majority of pleural plaques, they are not exclusive to asbestos exposure. Other conditions that have been reported to cause or mimic plaques include previous tuberculosis, prior bleeding into the chest cavity, old rib fractures, and exposure to certain other mineral fibers like erionite (a zeolite mineral found in volcanic rock in parts of Turkey and the western United States).

When bilateral calcified plaques are found in someone with no known asbestos exposure, doctors consider these alternative diagnoses, as well as rarer possibilities like early-stage mesothelioma or myeloma.

That said, in autopsy studies of urban populations, asbestos bodies were found in the lungs of about 85% of individuals who had pleural plaques, confirming that the vast majority of cases trace back to asbestos.

The Cancer Risk Question

This is where the conversation about pleural plaques gets more complicated. Plaques themselves are not cancerous and do not transform into cancer. But they serve as a visible marker that a person has had enough asbestos exposure to trigger a biological response, and that same exposure is what raises the risk of malignant mesothelioma and lung cancer. The question researchers have been wrestling with for decades is whether the plaques themselves are an independent risk factor for cancer, or whether they simply travel alongside the exposure that causes cancer.

A French study tracking asbestos-exposed workers found a roughly sevenfold increase in mesothelioma risk among those with pleural plaques compared to exposed workers without plaques, even after adjusting for the total amount and duration of asbestos exposure.

That adjusted figure suggests plaques are not merely a proxy for higher exposure. They seem to signal something about individual susceptibility or about the way fibers have distributed themselves in the body. A Scandinavian prospective study reached a similar conclusion, finding that plaques on a chest X-ray indicated significant past exposure and an elevated risk for both mesothelioma and possibly lung cancer.

Recent work has also uncovered an interaction with smoking. An extended follow-up study of formerly exposed workers found that the association between pleural plaques and lung cancer was strongest in non-smokers. Among non-smokers with plaques, lung cancer incidence was about three times higher than in non-smokers without plaques, after adjustment for asbestos exposure levels.

In smokers, the already-high baseline cancer risk from tobacco may have swamped the additional signal from plaques, making the association harder to detect statistically. This does not mean smoking is protective; it means that for non-smokers, the presence of plaques carries proportionally more warning weight.

Environmental Exposure Beyond the Workplace

When people think of asbestos exposure, they tend to picture factory workers or construction crews. But pleural plaques also occur in people who have never worked with asbestos directly. In parts of the world where asbestos-containing rock is naturally present in the soil, entire communities develop plaques from ambient environmental exposure.

A study in northeastern Corsica compared villagers living near natural asbestos outcrops with residents of a control village. Among those over 50, bilateral pleural plaques were found in 41% of the exposed village versus about 8% in the control village.

Similar findings have emerged from southeastern Turkey, where calcified pleural plaques were detected in about 30% of villagers living in areas with environmental asbestos exposure, along with diffuse pleural thickening in roughly 5%.

A cross-sectional study in another asbestos-exposed region found plaques in about 14% of villagers and noted that they were more common in men than women, with prevalence rates of 19% and 10% respectively.

These studies matter because they demonstrate that you do not need heavy occupational exposure to develop plaques. Living near asbestos-containing geological formations, or in older buildings with deteriorating asbestos-containing materials, can be enough. The same latency period of a decade or more still applies.

The Psychological Toll

Even though plaques are largely benign in physical terms, receiving a diagnosis tied to asbestos carries a psychological weight that the medical literature often underappreciates. Asbestos is so tightly associated with mesothelioma in the public imagination that learning you have “asbestos-related” changes on a scan can provoke real anxiety. Research on mental health in asbestos-exposed groups has found that people with known exposure tend to have lower mental health scores than the general population, though interestingly there was no significant difference in mental health between exposed individuals who had visible plaques on imaging and those who did not.

In other words, it seems to be the knowledge of exposure itself, rather than the radiographic finding, that drives the anxiety. This is worth knowing if you have recently been told about plaques on a scan. The plaques are not a death sentence, and the anxiety they trigger may be disproportionate to the actual medical risk they represent.

Monitoring and Biomarkers

Because pleural plaques flag a person as having had meaningful asbestos exposure, people with plaques are often placed on long-term surveillance programs. The goal is not to treat the plaques, which generally need no treatment, but to watch for early signs of more serious disease, particularly mesothelioma. Surveillance typically involves periodic CT scans and sometimes lung function testing.

Researchers have also investigated whether blood tests could add useful information. Biomarkers like mesothelin and its soluble form (SMRP), osteopontin, and thioredoxin (TRX) are being studied as potential early warning signals for mesothelioma. One study of people with environmental asbestos exposure found that those with plaques had significantly higher levels of mesothelin-related biomarkers compared to unexposed controls.

However, these biomarkers are still being evaluated for their accuracy in distinguishing between benign plaques and early malignancy, and they are not yet standard clinical tools for routine surveillance of plaque patients.

Compensation and Legal Recognition

Pleural plaques occupy an unusual legal space. Most countries formally recognize them as an occupational disease caused by asbestos exposure. However, because plaques alone rarely cause measurable disability, compensation for isolated plaques varies widely. A review of international approaches found that while nearly all countries accept asbestos-induced pleural plaques as occupationally related, financial compensation is typically reserved for cases with significant clinical impairment, defined as a restrictive lung disease with at least a 20% loss of pulmonary volume, a situation that is extremely rare in people who have only plaques.

In practice, this means many people with pleural plaques qualify for medical recognition and surveillance but not for disability payments. In some jurisdictions, the diagnosis can be used as supporting evidence in broader asbestos-related claims, especially if the person later develops mesothelioma or lung cancer. The legal landscape varies significantly by country and even by state or province, so anyone navigating this process should seek advice specific to their jurisdiction.

How Common They Are in Exposed Populations

Among workers with documented asbestos exposure, pleural plaques are remarkably prevalent. A large Finnish screening study of construction, shipyard, and asbestos industry workers found that about 17% had bilateral plaques and another 10% had unilateral plaques, making them by far the most common radiographic finding in the cohort.

In general urban populations, the rate is much lower but still detectable. Autopsy studies in cities have found plaques in roughly 7 to 12% of hospital cases, many of which were previously undiagnosed. The widespread use of asbestos in building construction, insulation, and shipbuilding through most of the twentieth century means low-level exposure was common even among people who did not think of themselves as asbestos workers.

With many countries now several decades past peak asbestos use, the prevalence of plaques in the general population will gradually decline. But in nations that continued to mine or use asbestos more recently, new cases will continue to emerge for decades due to the long latency period.